Incyte Corp (INCY) R&D head sells 10,640 shares in plan trade

Rhea-AI Filing Summary

Pablo J. Cagnoni, President and Global Head of R&D at Incyte, reported selling 10,640 shares of common stock on August 5, 2026 at $122.69 per share in a code S open-market or private transaction executed under a Rule 10b5-1 trading plan. Following the sale, he reports ownership of 204,804 shares, including 183,200 shares issuable from previously reported, unvested restricted stock units and earned performance stock units.

Insider Trade Summary 10b5-1

Net Seller: 10,640 shares

Net Sell 1 txn

Insider CAGNONI PABLO J

Role President, Global Head of R&D

Sold 10,640 shs ($1.31M)

Type	Security	Shares	Price	Value
Sale	Common Stock F1	10,640	$122.69	$1.31M

Holdings After Transaction: Common Stock — 204,804 shares (Direct)

Footnotes (1)

1. F1. This includes an aggregate of 183,200 shares of common stock issuable pursuant to previously reported restricted stock units and earned performance stock units that have not vested.

Key Figures

Shares sold: 10,640 shares Sale price: $122.69 per share Shares owned after sale: 204,804 shares +1 more

4 metrics

Shares sold 10,640 shares Common stock sold on August 5, 2026 in a code S transaction

Sale price $122.69 per share Price for the 10,640 Incyte common shares sold

Shares owned after sale 204,804 shares Reported total common stock holdings following the transaction

Unvested RSU/PSU underlying shares 183,200 shares Included within post-transaction holdings as unvested restricted and performance stock units

Key Terms

restricted stock units, performance stock units, open market or private transaction, Rule 10b5-1

4 terms

restricted stock units financial

"shares of common stock issuable pursuant to previously reported restricted stock units"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

performance stock units financial

"and earned performance stock units that have not vested"

Performance stock units are a type of company award that grants employees shares of stock only if certain performance goals are met. They motivate employees to work toward specific company achievements, aligning their interests with those of shareholders. For investors, they can influence a company's future stock supply and reflect management’s confidence in reaching key targets.

open market or private transaction financial

"transaction code description states: Sale in open market or private transaction"

Rule 10b5-1 financial

"aff_10b5_one indicates trades were under a Rule 10b5-1 trading plan"

Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 08/07/2026 - 04:02 PM Accepted by SEC EDGAR 08/07/2026 - 04:02 PM Learn about SEC filing dates

FAQ

What did Incyte (INCY) executive Pablo J. Cagnoni report in this Form 4 filing?

Pablo J. Cagnoni reported selling 10,640 shares of Incyte common stock on August 5, 2026 at $122.69 per share. The code S sale was an open-market or private transaction under a Rule 10b5-1 trading plan.

How many Incyte (INCY) shares did Pablo J. Cagnoni sell and at what price?

He sold 10,640 shares of Incyte common stock at a price of $122.69 per share. The transaction is reported as a code S open-market or private sale of non-derivative common stock.

How many Incyte (INCY) shares does Pablo J. Cagnoni hold after this transaction?

After the sale, Pablo J. Cagnoni reports owning 204,804 shares of Incyte common stock. This total includes both currently held shares and shares issuable from unvested equity awards disclosed in the filing footnote.

Were Pablo J. Cagnoni’s Incyte (INCY) share sales made under a Rule 10b5-1 plan?

Yes. The Form 4 indicates the transaction was executed under a Rule 10b5-1 trading plan via the document-level checkbox. Such plans prearrange trades, reducing the informational value of day-to-day timing.

How many of Pablo J. Cagnoni’s Incyte (INCY) shares are tied to unvested equity awards?

Within his reported 204,804-share position, 183,200 shares are issuable from previously reported, unvested restricted stock units and earned performance stock units. These shares are not yet vested but are included in the reported ownership figure.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

CAGNONI PABLO J

(Last) (First) (Middle)

1801 AUGUSTINE CUT-OFF

(Street)

WILMINGTON DELAWARE 19803

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
INCYTE CORP [ INCY ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President, Global Head of R&D

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/05/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/05/2026		S		10,640	D	$122.69	204,804(1)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. This includes an aggregate of 183,200 shares of common stock issuable pursuant to previously reported restricted stock units and earned performance stock units that have not vested.

Remarks:

	/s/ Elizabeth Feeney, Attorney-In-Fact	08/07/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)